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Purpose: To describe the finding of a novel calcium binding protein 4 (CABP4) mutation in a family with Leber congenital
amaurosis (LCA) phenotype.
Methods: Homozygosity mapping was performed in a consanguineous family with four affected members originally
referred as cases of LCA. Detailed electroretinographic recordings were obtained.
Results: A novel homozygous single base-pair insertion was identified in all four siblings. The patients had an LCA-like
phenotype, including either flat or greatly diminished electroretinographic activity.
Conclusions: This report significantly expands on the phenotype associated with calcium binding protein 4 mutations,
which has so far been limited to congenital stationary night blindness, and further demonstrates how molecular data often
blur the boundaries between what are believed to be clinically distinct retinal disorders.
The remarkable organization of retinal cells in layers
ensures  efficient  transmission  of  the  phototransduction
cascade that is initiated in photoreceptors to second- and third-
order neurons, before it is transmitted through the optic nerve.
Perturbation  of  the  phototransduction  cascade  or  its
transmission  adversely  affects  vision.  The  resulting
phenotype is known as congenital stationary night blindness
(CSNB).  Unlike  retinal  dystrophies,  CSNB  represents  a
functional retinal defect, since the clinical appearance of the
retina  in  these  patients  is  largely  normal  and  a  detailed
functional assessment of the retina is required to make the
diagnosis.  Several  proteins  involved  in  phototransduction
(TRPM1 [OMIM 603576], RHO [OMIM 180380], GNAT1
[OMIM 139330], PDE6B [OMIM 163500], GRK1 [OMIM
180381], and SAG [OMIM 181031]) have been implicated in
the  pathogenesis  of  CSNB  [1-6].  Similarly,  mutations  in
proteins  involved  in  the  communication  between
photoreceptors and the surrounding neurons are also etiologic
(CACNA1F [OMIM 300110], NYX [OMIM 300278], and
GRM6 [OMIM 604096]) [7-9]. These proteins are encoded
by genes that are both autosomal and X-linked, which explains
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why CSNB follows different modes of inheritance. Encoding
calcium-binding protein 4 (CABP4) was recently identified by
the candidate gene approach as a disease gene in autosomal
recessive CSNB [10]. Several characteristics made this an
attractive candidate: 1) its cellular localization to the synaptic
terminals of photoreceptors [11]; 2) its physical association
with  and  capacity  to  modulate  the  activity  of  Cav1.4α,  a
calcium channel that mediates the synaptic release of the
neurotransmitter glutamate from photoreceptors in the dark
[11]; and 3) the CSNB phenotype in Cabp4 knockout mice
[12]. Compared to the wild type, Cabp4−/− mice manifest a
50% reduction of the “a” wave (generated by photoreceptors),
and their “b” wave (generated by bipolar cells) was even more
markedly  reduced  [12].  So  far,  a  total  of  three  human
mutations have been reported in this gene [10,13]. Despite the
variability in the phenotype associated with these mutations,
electroretinography  (ERG)  findings  were  consistent  with
CSNB.  The  purpose  of  this  paper  is  to  describe  a  novel
frameshift mutation in CABP4 predicted to be more severe in
nature,  compared  to  those  reported  previously.  The  four
patients  had  a  clinical  presentation  highly  reminiscent  of
Leber  Congenital  Amaurosis  (LCA,  congenital  onset,
nystagmus,  severe  visual  impairment,  and  severely
diminished  or  extinguished  ERG),  which  expands  the
spectrum of the CABP4-associated phenotype.
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207METHODS
Human  subjects:  Four  siblings  (3  sisters  and  1  brother)
ranging in age from 6 to 16 years were referred to King Faisal
Specialist  Hospital  and  Research  Center  for  workup  of
nystagmus,  photophobia,  and  decreased  visual  acuity;  the
referral diagnosis was LCA. They were recruited under an
IRB-approved research protocol (REC#2070023, KFSHRC)
and a written informed consent was signed by each of the
subjects.  All  four  patients  underwent  a  comprehensive
ophthalmological  evaluation  that  included  best-corrected
visual acuity (VA), slit-lamp examination, funduscopy, and
full-field ERG (in accordance with International Society for
Clinical Electrophysiology of Vision standards) under both
scotopic  and  photopic  conditions.  Dilated  fundoscopic
photographs were acquired using Topcon Fundus Camera
(Topcon Medical Systems Inc., Paramus, NJ).
DNA extraction and genotyping: DNA was extracted from
whole blood using a Gentra Puregene Blood Kit (Qiagen,
Valencia, CA). Genomewide genotypes were obtained using
the Affymetrix SNP 250K Chip platform (Affymetrix, Santa
Clara, CA) following the manufacturer’s instructions. Blocks
of  homozygosity  were  identified  using  the  Affymetrix®
Genotyping Console™ (Affymetrix) as described in previous
studies [14,15]. Briefly, we use the default settings of the
Genotyping  Console™  to  identify  runs  of  homozygosity.
These are cross checked against a comprehensive list obtained
from the literature of all genes known to cause hereditary
retinal disorders to prioritize genes for sequencing.
Mutation analysis: CABP4 was PCR-amplified using primers
that covered the entire coding sequence, as well as the flanking
intronic sequences. PCR amplification was performed on a
thermocycler (Applied Biosystems, Foster City, CA) in a total
volume of 25 µl. PCR primers, as well as reaction conditions,
are available upon request. PCR amplicons were submitted
for  bidirectional  sequencing  using  an  Amersham  ET  Dye
Terminator Cycle Sequencing Kit (Amersham Biosciences;
Piscataway, NJ) following the manufacturer’s instructions.
Sequence analysis was performed using the SeqManII module
of the Lasergene (DNA Star Inc., Madison, WI) software
package, with a normal sequence used for comparison.
RESULTS
Clinical  phenotype:  Four  siblings  from  a  single  Bedouin
family were enrolled in this study, ranging in age from 6 to 16
years. The parents are first cousins and belong to a large tribe
in the central region of Saudi Arabia. To the best of our
knowledge, there is no history of CSNB in the extended family
members.  The  parents  were  unaffected  and  the  sibship
includes two unaffected siblings (Figure 1).
The index patient (II-3) was a 15-year-old Saudi girl with
an unremarkable perinatal history. The family noticed her
poor  vision  around  the  age  of  2–3  months,  evidenced  by
nystagmus and lack of fixation and tracking. She continued to
have very poor vision as a child and, despite prior evaluations,
no specific diagnosis was given to this patient except that she
had a “retinal disorder.” There was a history of photophobia,
but  not  night  blindness;  color  vision  was  normal.  Our
opthalmological  evaluation  revealed  the  presence  of
nystagmus, eccentric fixation, and poor visual acuity, with a
best-corrected VA of 20/400 in both eyes. This is not different
from  VA  obtained  in  early  childhood,  indicating  that  her
vision loss was stationary in nature, consistent with what was
volunteered in the history. Fundoscopy was largely normal,
apart from decreased foveal reflex. ERG was extinguished
under both photobic and scotobic conditions. The clinical
profile in other affected siblings was strikingly similar (Table
1 provides detailed ophthalmological findings in all affected
siblings).  However,  the  ERG  pattern  of  II-4  was  notably
different in that it was not extinguished, but rather severely
decreased under photopic conditions with normal implicit
time  on  photopic  flicker,  whereas  scopotopic  ERG  was
borderline, with normal oscillatory potential. Two girls (II-3
and II-4) were noticed early by the family to have strabismus,
and surgical correction of the strabismus was performed in
II-3. All four patients had normal intellect and growth. Other
systemic examinations were unremarkable.
Molecular analysis: Only one block of homozygosity was
identified as shared between the four siblings. The minimal
area  of  overlap  was  3.29  Mb  on  chromosome  11q13,
encompassing  157  genes,  including  CABP4  (accession
number NM_145200.2). In view of the recently described
phenotypes associated with CABP4 mutations in humans, this
appeared a good candidate. Direct sequencing revealed the
presence of a single base-pair insertion (c.81_82insA) in a
homozygous state in all affected siblings, while parents were
heterozygote carriers (Figure 1). This insertion introduced 44
novel amino acids before prematurely terminating the protein
(p.Pro28Thrfsx44) (Figure 2). The transcript was, therefore,
a potential target of NMD, but due to lack of availability of
RNA, we were unable to test this experimentally.
DISCUSSION
CSNB is a rare retinal disorder characterized by functionally
rather  than  structurally  defective  photoreceptors  that  are
unable  to  relay  their  electrical  impulses  to  the  adjacent
neurons. This disorder is therefore suspected when patients
present  with  a  history  suggestive  of  retinitis  pigmentosa
(nyctalopia and decreased visual acuity) in the setting of a
normal  fundus  exam.  ERG  is  considered  diagnostic,  with
different patterns reported in the different subtypes of CSNB
[13]. Recently, Littink et al. reported a family with a novel
nonsense  mutation  in  CABP4  and  a  clinical  picture  of
decreased visual acuity, photophobia, and nystagmus, but no
nyctalopia [13]. The authors of that paper noted that two of
the  three  families  reported  so  far  with  CABP4  mutations
lacked nyctalopia in their clinical presentation and suggested
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208that the term congenital cone-rod synaptic disorder be used as
a more accurate name than CSNB2 for this subtype. We are
in agreement with the suggestion, since this name reflects the
true pathogenesis of this condition.
Table  1  summarizes  the  molecular  and  clinical
characteristics  of  human  patients  with  CABP4  mutations.
Three mutant alleles have been described in five patients
representing  three  Caucasian  families.  Our  report  adds  a
fourth allele and four patients representing one Arab family
with this disorder. Interestingly, the three previously reported
mutations were most likely hypomorphic in nature. In the case
of c.800_801delAG, it was predicted to elongate the otherwise
276 amino acid-long CABP4 by another 91 novel amino acids
(p.Glu267fsX91). The introduction of the novel amino acids
was  downstream  of  the  last  Ca-binding  motif,  making  it
unlikely to directly interfere with that function of the protein
[10].  However,  this  mutation  was  found  to  significantly
reduce  the  abundance  of  the  wild-type  transcript,  so  the
authors speculated that a combination of change in the tertiary
structure and a reduction in transcriptional efficiency was
responsible  for  the  pathogenicity  of  this  mutation  [10].
Interestingly, this mutation was found to display a founder
effect in another patient who was compound heterozygous for
the only missense mutation reported in CABP4 (Arg124Cys)
[10].  It  is  unclear  how  this  missense  mutation  adversely
affects the protein function, since it does not reside within any
of the four Ca-binding motifs. Indeed, the authors speculated
the effect may in fact be at the level of transcription, because
compound  heterozygosity  for  this  mutation  and  c.
800_801delAG, just like homozygosity for the latter, was
associated  with  decreased  abundance  of  the  wild-type
transcript  [10].  The  third  mutation,  p.Arg216X,  was  also
speculated to be hypomorphic in nature, since it does not
undergo NMD and only truncates two of the four Ca-binding
motifs [13]. Our mutation, on the other hand, is very likely to
be a complete null. Even if the mutant transcript escapes
NMD, the introduction of novel amino acids very early in the
protein  will  abolish  all  Ca-binding  motifs  and  essentially
render the protein functionally absent (Figure 2). Therefore,
our  mutation  is  predicted  to  result  in  the  most  dramatic
functional perturbation of this important protein, and this may
explain the more severe phenotype observed in our patients,
Figure 1. Family pedigree with a novel
CABP4  mutation.  The  upper  panel
shows the pedigree of a consanguineous
family with four affected children. The
square denotes male, the circle denotes
female,  the  central  dot  indicates  the
carrier  state,  and  the  solid  filling
indicates the affected state. The lower
panel  shows  sequence  chromatogram
with the site of insertion indicated by the
arrow.  Carrier  and  Normal  (same
family) are shown for comparison.
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210compared to others (Table 1). LCA and CSNB are usually
considered distinct clinical entities. The congenital onset of
symptoms in our patients and their extinguished ERG (Figure
3) argue for their classification as LCA [16]. However, lack
of enophthalmos and Franceschetti's oculo-digital sign in our
patients must be noted. The normal appearance of the fundus
in the four patients should not be viewed as evidence against
LCA, since GUCY2D-related LCA is known to be associated
with a normal-looking fundus, even in adults [17]. However,
the  stationary  nature  of  the  disease  observed  in  our  four
patients does complicate their classification as LCA, which is
known to be progressive in nature. Nonetheless, this family
provides a unique opportunity to observe a severe retinal
phenotype that resembles LCA caused by a mutation in a gene
hitherto described as a CSNB gene.
In summary, our study is in line with our previous reports
of the clinical utility of homozygosity mapping in the setting
of  genetically  heterogeneous  disorders.  It  expands  on  the
Figure 2. Schematic of CABP4 gene. Previously reported mutations are indicated by empty triangles, and our novel mutation is indicated by
a solid triangle.
Figure 3. ERG findings in a family with an LCA-like phenotype secondary to the CABP4 mutation. Scotopic and photopic ERG readings are
shown for each of the four affected members, who are referred to using the IDs in Figure 1 and Table 1 (II-2, II-3, II-4, and II-6).
Molecular Vision 2010; 16:207-212 <http://www.molvis.org/molvis/v16/a26> © 2010 Molecular Vision
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retinal phenotype associated with mutations in CABP4, and
makes it necessary to consider this gene in the context of LCA-
like presentations with extinguished ERG.
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